Clinical trial
A Pilot Study Assessing Duloxetine's Efficacy in Atypical Depression
NCT00296699 · New York State Psychiatric Institute, Other · Completed
Key facts
| NCT number | NCT00296699 |
|---|---|
| Title | A Pilot Study Assessing Duloxetine's Efficacy in Atypical Depression |
| Official title | A Pilot Study Assessing Duloxetine's Efficacy in Atypical Depression |
| Lead sponsor | New York State Psychiatric Institute, Other |
| Collaborators | Eli Lilly and Company Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Atypical Depression |
| Intervention type | Drug |
| Interventions | Duloxetine |
| Enrollment | 20 |
| Start date | Mar 1, 2005 |
| Primary completion | Jun 1, 2007 |
| First posted | Feb 27, 2006 |
| Last update posted | Jan 15, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: